Rong Tao

2.6k total citations
73 papers, 1.8k citations indexed

About

Rong Tao is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Rong Tao has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 26 papers in Oncology and 24 papers in Pathology and Forensic Medicine. Recurrent topics in Rong Tao's work include Lymphoma Diagnosis and Treatment (20 papers), Viral-associated cancers and disorders (10 papers) and CAR-T cell therapy research (9 papers). Rong Tao is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Viral-associated cancers and disorders (10 papers) and CAR-T cell therapy research (9 papers). Rong Tao collaborates with scholars based in China, United States and Hong Kong. Rong Tao's co-authors include Joel S. Karliner, Conrad C. Alano, Qin Fan, Hung‐Fat Tse, Norman Honbo, Lin Lu, Chu‐Pak Lau, Ruiyan Zhang, Xiaoxiang Yan and Gang Li and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Rong Tao

68 papers receiving 1.8k citations

Peers

Countries citing papers authored by Rong Tao

Since Specialization

Citations

This map shows the geographic impact of Rong Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Tao more than expected).

Fields of papers citing papers by Rong Tao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Tao. The network helps show where Rong Tao may publish in the future.

Co-authorship network of co-authors of Rong Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Tao. A scholar is included among the top collaborators of Rong Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Tao. Rong Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ocular manifestations of patients with extranodal NK/T-cell lymphoma 2025 ·Eye ·Jia Luo, Rong Tao, (unknown), Yujie Ma, (unknown), Jing Li, Peiquan Zhao, Ping Fei	0
2	SKYGLO: A Global Phase III Randomized Study Evaluating Glofitamab Plus Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients with Large B-Cell Lymphoma (LBCL) 2024 ·Blood ·Ranjana H. Advani, Michael Dickinson, Christopher P. Fox, Brad S. Kahl, Alex F. Herrera, Georg Lenz, Yuqin Song, Rong Tao, (unknown), (unknown), Michelle Y. Doral, Derrick Kaufman, Leonardo Pereira, (unknown), Franck Morschhauser	6
3	193P The association between FGF19 expression and clinical outcomes in unresectable hepatocellular carcinoma (uHCC) patients (pts) receiving immune checkpoint inhibitor (ICI)-based therapies 2024 ·Annals of Oncology ·Qi Cheng, (unknown), (unknown), (unknown), Rong Tao, (unknown), (unknown)	1
4	Optimal timing and impact of allogeneic peripheral blood stem cell transplantation in adult T-cell lymphoblastic lymphoma: insights from a large cohort multi-center real-world study in Shanghai 2024 ·Bone Marrow Transplantation ·Fangfang Yu, (unknown), Jianmin Yang, (unknown), Siguo Hao, Aibin Liang, (unknown), Qi Zhu, (unknown), Jun Shi, Juan Du, Bobin Chen, Rong Wei, Wenli Zhao, (unknown), (unknown), Rong Tao, Xianmin Song	0
5	Anti-PD-1 Antibody Sintilimab in Combination with Anlotinib and Pegaspargase As a Highly Effective Salvage Regimen for the Treatment of Relapsed or Refractory Natural Killer /T-Cell Lymphoma 2023 ·Blood ·Rong Tao, Chuanxu Liu, Wenhao Zhang, Yang Zhu, Yujie Ma	1
6	PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway 2023 ·Biomolecules ·Qian Yang, (unknown), Lingfang Zhuang, (unknown), (unknown), Qin Fan, Rong Tao	6
7	The Prognostic Significance of Secondary Mitral Regurgitation in Heart Failure Patients with Varying Estimated Pulmonary Artery Systolic Pressure 2023 ·Reviews in Cardiovascular Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Rui Xi, (unknown), Rong Tao	0
8	Depression Following Acute Coronary Syndrome: A Review 2023 ·Reviews in Cardiovascular Medicine ·(unknown), (unknown), Rong Tao	3
9	Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4) 2021 ·Signal Transduction and Targeted Therapy ·Rong Tao, Lei Fan, Yongping Song, Yu Hu, Wei Zhang, (unknown), Wei Xu, Jianyong Li	65
10	FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway 2021 ·Frontiers in Cardiovascular Medicine ·Lingfang Zhuang, Mao Ye, (unknown), (unknown), Qi Jin, Lin Lu, Rong Tao, Xiaoxiang Yan, Kang Chen	30
11	High Proteoglycan Decorin Levels Are Associated With Acute Coronary Syndrome and Provoke an Imbalanced Inflammatory Response 2021 ·Frontiers in Physiology ·Lingfang Zhuang, (unknown), (unknown), Qian Yang, Ruiyan Zhang, Qin Fan, Rong Tao	6
12	Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type 2019 ·Cancer Medicine ·Shu Tian, (unknown), Tian Wang, Shengzi Wang, Rong Tao, Xichun Hu, Hao Ding	8
13	MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment 2019 ·Journal for ImmunoTherapy of Cancer ·Douglas D. Fang, Qiuqiong Tang, (unknown), Qixin Wang, (unknown), Fang Xu, Peng Zou, Rong Tao, Jingwen Wang, Dajun Yang, Yifan Zhai	118
14	Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome 2017 ·Frontiers in Endocrinology ·Hang Zhang, Qin Fan, Hongyang Xie, (unknown), Rong Tao, Fang Wang, Rui Xi, Jian Hu, Qiujing Chen, Weifeng Shen, Ruiyan Zhang, Xiaoxiang Yan	21
15	IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure 2016 ·Scientific Reports ·Qin Fan, Xiaoxiang Yan, Hang Zhang, Lin Lu, Qi Zhang, Fang Wang, Rui Xi, Jian Hu, Qiujing Chen, Wenquan Niu, Weifeng Shen, Ruiyan Zhang, Rong Tao	32
16	Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients 2015 ·Chinese Medical Journal ·(unknown), Ying Shen, (unknown), Lin Lu, Qi Zhang, Ruiyan Zhang, Weifeng Shen, Rong Tao	1
17	Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia 2012 ·International Journal of Hematology ·Hui Yang, Hui Liang, (unknown), Rong Tao, Siguo Hao, Liyuan Ma	18
18	Cyclic ADP ribose is a novel regulator of intracellular Ca2+ oscillations in human bone marrow mesenchymal stem cells 2011 ·Journal of Cellular and Molecular Medicine ·Rong Tao, Hai‐Ying Sun, Chu‐Pak Lau, Hung‐Fat Tse, (unknown), Gang Li	28
19	Vincristine attenuates doxorubicin cardiotoxicity 2008 ·Biochemical and Biophysical Research Communications ·Kanu Chatterjee, Jianqing Zhang, Rong Tao, Norman Honbo, Joel S. Karliner	34
20	Differences among cell types in NAD⁺ compartmentalization: A comparison of neurons, astrocytes, and cardiac myocytes 2007 ·Journal of Neuroscience Research ·Conrad C. Alano, (unknown), Rong Tao, Weihai Ying, Joel S. Karliner, Raymond A. Swanson	98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact